We are live on ! Find out more
LIM

Lagoda Investment Management Portfolio holdings

AUM $162M
1-Year Est. Return 49.7%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$258M
AUM Growth
-$33.5M
Cap. Flow
-$38M
Cap. Flow %
-14.73%
Top 10 Hldgs %
79.97%
Holding
41
New
1
Increased
2
Reduced
26
Closed
5

Top Buys

Rank Stock Value
1
UI icon
Ubiquiti
UI
+$920K
2
TPL icon
Texas Pacific Land
TPL
+$729K
3
AQB icon
AquaBounty Technologies
AQB
+$28.1K

Sector Composition

Rank Sector Weight
1 Healthcare 40.57%
2 Technology 24.13%
3 Financials 12.36%
4 Communication Services 11.11%
5 Materials 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNR icon
1
RenaissanceRe
RNR
$13.3B
$26.9M 10.43%
185,840
-16,987
-8% -$2.43M
REGN icon
2
Regeneron Pharmaceuticals
REGN
$78.5B
$26.8M 10.4%
69,133
-3,884
-5% -$1.44M
SGEN
3
DELISTED
Seagen Inc. Common Stock
SGEN
$24.8M 9.61%
394,090
-123,739
-24% -$7.72M
PTC icon
4
PTC
PTC
$15.8B
$24.2M 9.37%
459,627
-38,123
-8% -$2.02M
UI icon
5
Ubiquiti
UI
$33.7B
$21.2M 8.23%
422,129
+16,843
+4% +$920K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.36T
$19.9M 7.71%
478,740
-65,320
-12% -$2.68M
MON
7
DELISTED
Monsanto Co
MON
$18M 6.98%
158,879
-15,189
-9% -$1.68M
DMRC icon
8
Digimarc Corp
DMRC
$147M
$16.4M 6.38%
608,493
-33,420
-5% -$875K
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$14.3M 5.55%
117,945
-43,257
-27% -$5.58M
NVO
10
Novo Nordisk
NVO
$208B
$13.7M 5.31%
798,026
-98,110
-11% -$1.71M
VNRX icon
11
VolitionRx Ltd
VNRX
$8.65M
$11.8M 4.59%
146,954
-6,766
-4% -$599K
TTOO
12
DELISTED
T2 Biosystems, Inc
TTOO
$9M 3.49%
342
-5
-1% -$141K
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.36T
$8.76M 3.4%
206,700
-13,440
-6% -$565K
PGEN icon
14
Precigen
PGEN
$2.24B
$8.24M 3.2%
415,890
-33,621
-7% -$751K
ESGR
15
DELISTED
Enstar Group
ESGR
$3.6M 1.4%
18,820
-1,008
-5% -$195K
TPL icon
16
Texas Pacific Land
TPL
$27.8B
$2.61M 1.01%
84,024
+21,672
+35% +$729K
MACK
17
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.39M 0.93%
98,575
-94,938
-49% -$2.38M
SNMX
18
DELISTED
Senomyx, Inc.
SNMX
$2.37M 0.92%
2,391,308
-373,294
-14% -$412K
BRK.A icon
19
Berkshire Hathaway Class A
BRK.A
$1.1T
$500K 0.19%
2
MSFT icon
20
Microsoft
MSFT
$3.45T
$383K 0.15%
5,820
-359
-6% -$23K
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.1T
$373K 0.14%
2,235
-180
-7% -$30.1K
Y
22
DELISTED
Alleghany Corp
Y
$280K 0.11%
455
-15
-3% -$9.36K
MA icon
23
Mastercard
MA
$502B
$201K 0.08%
1,785
-17,675
-91% -$1.94M
BF.B icon
24
Brown-Forman Class B
BF.B
$13.2B
$194K 0.08%
6,575
XOM icon
25
ExxonMobil
XOM
$644B
$182K 0.07%
2,215

Similar funds

Lagoda Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Lagoda Investment Management held 41 positions worth $258M, down 12% from $291M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Lagoda Investment Management withdrew a net $38M in Q1 2017, closing 5 positions and reducing 26 holdings. Its most notable exit was Baidu, an estimated $5.94M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Technology and Financials.

Against the trend, Lagoda Investment Management opened a new position in AquaBounty Technologies worth $22K.

  • Lagoda Investment Management's largest Q1 2017 buy was AquaBounty Technologies: 100 shares worth $22K.
  • Lagoda Investment Management added most to Ubiquiti in Q1 2017, an estimated $920K increase.
  • Lagoda Investment Management's biggest Q1 2017 reduction was Seagen Inc. Common Stock, cutting an estimated $7.72M.
  • Lagoda Investment Management fully exited Baidu in Q1 2017, selling an estimated $5.94M.
  • Lagoda Investment Management's ten largest holdings make up 80% of its $258M portfolio in Q1 2017.
  • Lagoda Investment Management opened 1 new position and closed 5 in Q1 2017.
  • Lagoda Investment Management's portfolio value fell 12% quarter-over-quarter to $258M.

Based on Lagoda Investment Management's 13F filing for Q1 2017, filed 15 May 2017.